Oncology Community Unites to Bring Innovation to Patients With Cancer

September 2020.

Some of the most exciting new data at this year’s congress included advancements in lung cancer, breast cancer, genitourinary cancers, and gastrointestinal cancers. Several experts spoke with Targeted Oncology to share their thoughts on some of the most impactful abstracts from the 2020 ESMO Congress.

Breast Cancer

During the 2020 ESMO Congress, a number of studies were presented in the breast cancer field, but some of the most exciting data in this space revolved around targeted therapies. Several agents demonstrated promising data in clinical trials across a variety of subgroups of patients with breast cancer.

“There was good new data in breast cancer, and there were some less good or maybe contrasting results in some of the trials,” said Vorobiof. “I think from the breast cancer point of view, there were [many] interesting data, and some of them will become standard treatments, in the near future.”

Continue Reading >

More Articles

Smart Menopause Support with Ask Elina – Powered by Belong’s AI

Ask Elina Helps Women Navigate perimenopause and Menopause….

Belong’s AI Technology Helps Women Navigate Menopause

A Canadian tech company is using Belong’s AI to help women get accurate menopause guidance….

New app uses Belong’s AI technology to fill gaps in menopause support

Belong.Life, the developer of AI-driven patient education and engagement solutions, has announced that its AI…
Skip to content